Literature DB >> 15915360

[Slipped capital femoral epiphysis and overweight].

A K Hell1.   

Abstract

The slipped capital femoral epiphysis (SCFE) is defined as a nontraumatic epiphyseal separation and slipping of the proximal femoral epiphysis, which usually occurs during the adolescent growth spurt. Slipping of the upper femoral epiphysis may be classified as acute, chronic, and acute on chronic. The etiology of the disease is still not fully understood but seems to be multifactorial. The typical SCFE during puberty has to be differentiated from the atypical form, which may be associated with an endocrinological disorder or with its therapy. The typical SCFE may be found in male patients, with increased height and weight. It is likely that the growth rate is slightly accelerated before slippage. Obesity is often associated with a decreased femoral anteversion accounting for abnormal mechanical shear forces at the growth plate. SCFE is treated surgically. Surgical methods are administered according to the degree of disease. Because of possible alterations of blood supply to the femoral head, acute SCFE is an emergency. Following SCFE, complications such as chondrolysis and avascular necrosis are feared.

Entities:  

Mesh:

Year:  2005        PMID: 15915360     DOI: 10.1007/s00132-005-0820-y

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  37 in total

1.  [Surgical treatment of pathological anteversion of the proximal femur].

Authors:  G IMHAUSER
Journal:  Z Orthop Ihre Grenzgeb       Date:  1954

Review 2.  [Epiphyseolysis capitis femoris].

Authors:  R Krauspe; K Seller; B Westhoff
Journal:  Z Orthop Ihre Grenzgeb       Date:  2004 Sep-Oct

3.  Femoral version in acute slipped capital femoral epiphysis.

Authors:  C L Stanitski; R Woo; D F Stanitski
Journal:  J Pediatr Orthop B       Date:  1996       Impact factor: 1.041

4.  Slipped capital femoral epiphysis. A report of 4 cases occurring in one family.

Authors:  J F Moreira; M C Neves; G Lopes; A R Gomes
Journal:  Int Orthop       Date:  1998       Impact factor: 3.075

5.  The association of femoral retroversion with slipped capital femoral epiphysis.

Authors:  R H Gelberman; M S Cohen; B A Shaw; J R Kasser; P P Griffin; R H Wilkinson
Journal:  J Bone Joint Surg Am       Date:  1986-09       Impact factor: 5.284

6.  Mechanical factors in slipped capital femoral epiphysis.

Authors:  J W Pritchett; K D Perdue
Journal:  J Pediatr Orthop       Date:  1988 Jul-Aug       Impact factor: 2.324

7.  [Treatment of acute slips and clinical results in slipped capital femoral epiphysis].

Authors:  G U Exner; P A Schai; H P Nötzli
Journal:  Orthopade       Date:  2002-09       Impact factor: 1.087

8.  Obesity and decreased femoral anteversion in adolescence.

Authors:  R T Galbraith; R H Gelberman; P C Hajek; L A Baker; D J Sartoris; G T Rab; M S Cohen; P P Griffin
Journal:  J Orthop Res       Date:  1987       Impact factor: 3.494

Review 9.  Slipped capital femoral epiphysis associated with endocrine disorders.

Authors:  R T Loder; B Wittenberg; G DeSilva
Journal:  J Pediatr Orthop       Date:  1995 May-Jun       Impact factor: 2.324

10.  Slipped capital femoral epiphysis: etiology and treatment.

Authors:  Seiya Jingushi; Eiji Suenaga
Journal:  J Orthop Sci       Date:  2004       Impact factor: 1.601

View more
  3 in total

1.  The big idea: paediatric oncological pathology--a new phenomenon.

Authors:  Ekf Lacey; Nmp Clarke
Journal:  J R Soc Med       Date:  2008-06       Impact factor: 5.344

2.  Get up, get out, get moving: an interactive tool for education at your local school.

Authors:  Jennifer Weiss; Elizabeth Matzkin; Michael Flippin; Mark Pallis; Mark Rankin
Journal:  Clin Orthop Relat Res       Date:  2013-04       Impact factor: 4.176

3.  A reduction in body mass index lowers risk for bilateral slipped capital femoral epiphysis.

Authors:  Adam Y Nasreddine; Benton E Heyworth; David Zurakowski; Mininder S Kocher
Journal:  Clin Orthop Relat Res       Date:  2013-07       Impact factor: 4.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.